Literature DB >> 17409752

Risk factors for mortality of nosocomial bacteraemia in intensive care units.

A Atahan Cağatay1, Perihan Ergin Ozcan, Leyla Gulec, Nurhan Ince, Simru Tugrul, Halit Ozsut, Nahit Cakar, Figen Esen, Haluk Eraksoy, Semra Calangu.   

Abstract

OBJECTIVE: The aim of this study was to follow critically ill patients prospectively in intensive care units (ICUs) to determine risk factors for mortality and outcome associated with nosocomial bacteraemia (NB). SUBJECTS AND METHODS: A case-control study of 176 patients was conducted to identify the risk factors for mortality of NB in ICU patients. The study was performed in emergency, surgical and general surgical ICUs with 23 beds during a 15-month period. A total of 1,450 patients were admitted to the ICUs during the study period. The USA Center for Disease Control and Prevention definitions were used to diagnose nosocomial infections. Nosocomial bacteraemia was defined as the isolation of one or more organisms from blood cultures taken at least 48 h after admission, which were not related to a problem present on admission. An assessment of whether the isolated organisms represented true bacteraemia rather than contamination was made by clinical or laboratory evidence of infection.
RESULTS: A total of 214 bacteraemia episodes were found in the 176 patients (64 female, 112 male; 51.3 +/- 21.3 years old), 90 of whom died and 86 survived. The bacteraemia rate was 12.1%. The most common etiological agents of bacteraemia were Klebsiella pneumoniae: 46 (21.5%), methicillin-resistant Staphylococcus aureus: 46 (21.5%), Pseudomonas aeruginosa: 32 (14.9%), and Escherichia coli: 20 (9.3%). Multivariate analysis showed that the requirement of mechanical ventilation for more than 7 days (p < 0.001), total parenteral nutrition (p = 0.034), inotropic drug (p < 0.001), and increased creatinine level (p = 0.034) were independent risk factors for mortality of NB in ICUs.
CONCLUSIONS: Nosocomial infections caused by Gram-negative bacteria continue to be one of the major sources of morbidity and mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17409752     DOI: 10.1159/000100388

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  8 in total

1.  External validation of bloodstream infection mortality risk score in a population-based cohort.

Authors:  M N Al-Hasan; Y J Juhn; D W Bang; H-J Yang; L M Baddour
Journal:  Clin Microbiol Infect       Date:  2014-03-26       Impact factor: 8.067

2.  Nosocomial infections and antimicrobial resistance pattern in a tertiary referral hospital in Hamedan, Iran.

Authors:  Mitra Ranjbar; Amir Houshang Mohammad Alizadeh; Hamideh Khorram Pazhooh; Khosro Mani Kashani; Mohammad Golmohammadi; Marzieh Nojomi
Journal:  Int J Crit Illn Inj Sci       Date:  2012-01

Review 3.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

4.  Healthcare-associated bloodstream infections in critically ill patients: descriptive cross-sectional database study evaluating concordance with clinical site isolates.

Authors:  Nick Culshaw; Guy Glover; Craig Whiteley; Katie Rowland; Duncan Wyncoll; Andrew Jones; Manu Shankar-Hari
Journal:  Ann Intensive Care       Date:  2014-11-25       Impact factor: 6.925

5.  Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections.

Authors:  Matthias Karer; Manuel Kussmann; Franz Ratzinger; Markus Obermueller; Veronika Reischer; Heidemarie Winkler; Richard Kriz; Heinz Burgmann; Bernd Jilma; Heimo Lagler
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

6.  Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine.

Authors:  Susanne Schjørring; Carsten Struve; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2008-08-13       Impact factor: 5.790

7.  A new multiplex polymerase chain reaction assay for the identification a panel of bacteria involved in bacteremia.

Authors:  Hossein Fazzeli; Mohammad R Arabestani; Bahram N Esfahani; Farzin Khorvash; Mohammad R Pourshafie; Sharareh Moghim; Hajieh G Safaei; Jamshid Faghri; Amir Azimian
Journal:  Adv Biomed Res       Date:  2013-03-06

8.  Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.

Authors:  Eun-Jeong Joo; Dong Ah Park; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Sang Moo Lee; Kyong Ran Peck
Journal:  Korean J Intern Med       Date:  2018-01-20       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.